In early-onset severe hemolytic disease of the fetus and newborn (HDFN), transplacental transfer of maternal antierythrocyte IgG alloantibodies causes fetal anemia that leads to the use of high-risk ...
Researchers are leading a study into nipocalimab, a new investigational drug that's showing promise in treating a rare blood disease in babies. It could help prevent anemia and cut down on the need ...